The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Live attenuated vaccines: Historical successes and current challenges
Open accessAbstract
Live attenuated vaccines against human viral diseases have been amongst the most successful cost effective interventions in medical history. Smallpox was declared eradicated in 1980; poliomyelitis is nearing global eradication and measles has been controlled in most parts of the world. Vaccines function well for acute diseases such as these but chronic infections such as HIV are more challenging for reasons of both likely safety and probable efficacy. The derivation of the vaccines used has in general not been purely rational except in the sense that it has involved careful clinical trials of candidates and subsequent careful follow up in clinical use; the identification of the candidates is reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KIM, H. W., CANCHOLA, J. G., BRANDT, C. D., PYLES, G., CHANOCK, R. M., JENSEN, K., & PARROTT, R. H. (1969) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120955 · Cited by 1,981
Santos, N., & Hoshino, Y. (2005) · Reviews in Medical Virology · doi:10.1002/rmv.448 · Cited by 1,251
Capeding, M. R., Tran, N. H., Hadinegoro, S. R. S., Ismail, H. I. H. M., Chotpitayasunondh, T., Chua, M. N., Luong, C. Q., Rusmil, K., Wirawan, D. N., Nallusamy, R., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61060-6 · Cited by 973
Nucleotide Sequence of Yellow Fever Virus: Implications for Flavivirus Gene Expression and Evolution
Rice, C. M., Lenches, E. M., Eddy, S. R., Shin, S. J., Sheets, R. L., & Strauss, J. H. (1985) · Science · doi:10.1126/science.4023707 · Cited by 961
Measles Antibody: Reevaluation of Protective Titers
Chen, R. T., Markowitz, L. E., Albrecht, P., Stewart, J. A., Mofenson, L. M., Preblud, S. R., & Orenstein, W. A. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.5.1036 · Cited by 608
Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., et al. (2002) · Science · doi:10.1126/science.1068284 · Cited by 600
THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION
Theiler, M., & Smith, H. H. (1937) · Journal of Experimental Medicine · doi:10.1084/jem.65.6.787 · Cited by 445
HUMAN EXPOSURE TO SV40: REVIEW AND COMMENT12
SHAH, K., & NATHANSON, N. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112197 · Cited by 339
Vesikari, T., Isolauri, E., D'Hondt, E., Delem, A., André, F., & Zissis, G. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92323-7 · Cited by 339
History of Sabin attenuated poliovirus oral live vaccine strains
Sabin, A. B., & Boulger, L. R. (1973) · Journal of Biological Standardization · doi:10.1016/0092-1157(73)90048-6 · Cited by 319
Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans
Watkins, D. I., Burton, D. R., Kallas, E. G., Moore, J. P., & Koff, W. C. (2008) · Nature Medicine · doi:10.1038/nm.f.1759 · Cited by 297
Fulginiti, V. A. (1967) · JAMA · doi:10.1001/jama.1967.03130250057008 · Cited by 273
Hahn, C. S., Dalrymple, J. M., Strauss, J. H., & Rice, C. M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.2019 · Cited by 253
Priddy, F. H., Brown, D., Kublin, J., Monahan, K., Wright, D. P., Lalezari, J., Santiago, S., Marmor, M., Lally, M., Novak, R. M., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587993 · Cited by 253
Emerging Concept of Poliomyelitis Infection
Bodian, D. (1955) · Science · doi:10.1126/science.122.3159.105 · Cited by 251
Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984
Nkowane, B. M. (1987) · JAMA · doi:10.1001/jama.257.10.1335 · Cited by 240
Pathogenesis of Poliomyelitis Reappraisal in the Light of New Data
Sabin, A. B. (1956) · Science · doi:10.1126/science.123.3209.1151 · Cited by 236
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine
Westrop, G. D., Wareham, K. A., Evans, D. M., Dunn, G., Minor, P. D., Magrath, D. I., Taffs, F., Marsden, S., Skinner, M. A., & Schild, G. C. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1338-1344.1989 · Cited by 233
Self-citationSalk, J. E., Bennett, B. L., Lewis, L. J., Ward, E. N., & Youngner, J. S. (1953) · Journal of the American Medical Association · doi:10.1001/jama.1953.13.1081 · Cited by 218
Monath, T. P., McCarthy, K., Bedford, P., Johnson, C. T., Nichols, R., Yoksan, S., Marchesani, R., Knauber, M., Wells, K. H., Arroyo, J., et al. (2002) · Vaccine · doi:10.1016/s0264-410x(01)00457-1 · Cited by 217
The molecular biology of poliovaccines
Minor, P. D. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-12-3065 · Cited by 217
Self-citationPaul, J. R. (1971) · Cited by 208
Yellow fever vaccine — how does it work and why do rare cases of serious adverse events take place?
Barrett, A. D., & Teuwen, D. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.018 · Cited by 203
Minor, P. D., John, A., Ferguson, M., & Icenogle, J. P. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-4-693 · Cited by 203
Self-citationGenetic analysis of the attenuation phenotype of poliovirus type 1
Omata, T., Kohara, M., Kuge, S., Komatsu, T., Abe, S., Semler, B. L., Kameda, A., Itoh, H., Arita, M., & Wimmer, E. (1986) · Journal of Virology · doi:10.1128/jvi.58.2.348-358.1986 · Cited by 190
Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans
Nottay, B. K., Kew, O. M., Hatch, M. H., Heyward, J. T., & Obijeski, J. F. (1981) · Virology · doi:10.1016/0042-6822(81)90448-7 · Cited by 190
Live Attenuated Mumps Virus Vaccine. 1. Vaccine Development
Buynak, E. B., & Hilleman, M. R. (1966) · Experimental Biology and Medicine · doi:10.3181/00379727-123-31599 · Cited by 181
Edmonson, M. B. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440180073035 · Cited by 175
Norrby, E., Enders-Ruckle, G., & ter Meulen, V. (1975) · The Journal of Infectious Diseases · doi:10.1093/infdis/132.3.262 · Cited by 169
MacLennan, C., Dunn, G., Huissoon, A. P., Kumararatne, D. S., Martin, J., O'Leary, P., Thompson, R. A., Osman, H., Wood, P., Minor, P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16150-3 · Cited by 162
Self-citationSTUDIES ON VARIANTS OF POLIOMYELITIS VIRUS
Sabin, A. B., Hennessen, W., & Winsser, J. (1954) · The Journal of Experimental Medicine · doi:10.1084/jem.99.6.551 · Cited by 155
Polack, F. P., Auwaerter, P. G., Lee, S.-H., Nousari, H. C., Valsamakis, A., LEIFERMAN, K. M., Diwan, A. R., Adams, R. J., & Griffin, D. E. (1999) · Nature Medicine · doi:10.1038/9473 · Cited by 154
Chumakov, K., Powers, L., Noonan, K. E., Roninson, I. B., & Levenbook, I. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.199 · Cited by 153
Rotavirus Vaccines: Targeting the Developing World
Glass, R. I., Bresee, J., Turcios, R. M., Fischer, T. K., Parashar, U. D., & Steele, A. D. (2005) · The Journal of Infectious Diseases · doi:10.1086/431504 · Cited by 147
Genetic basis of attenuation of the Sabin type-2 vaccine strain of poliovirus in primates.
Macadam, A. J., Pollard, S. R., Ferguson, G., Skuce, R., Wood, D., Almond, J. W., & Minor, P. D. (1993) · Virology · doi:10.1006/viro.1993.1003 · Cited by 139
Self-citationDevelopment and Evaluation of the Moraten Measles Virus Vaccine
Hilleman, M. R. (1968) · JAMA · doi:10.1001/jama.1968.03150030043009 · Cited by 134
Genetic Characterization of Measles Vaccine Strains
Bankamp, B., Takeda, M., Zhang, Y., Xu, W., & Rota, P. A. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir097 · Cited by 130
THE NATURAL HISTORY OF HUMAN POLIOMYELITIS
Sabin, A. B., & Ward, R. (1941) · The Journal of Experimental Medicine · doi:10.1084/jem.73.6.771 · Cited by 123
Svitkin, Y. V., Cammack, N., Minor, P. D., & Almond, J. W. (1990) · Virology · doi:10.1016/0042-6822(90)90190-3 · Cited by 116
Self-citationAaby, P., Knudsen, K., Whittle, H. C., Lisse, I. M., Thaqrup, J., Poulsen, A., Sodemann, M., Jakobsen, M., Brink, L., Gansted, U., et al. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(09)90015-4 · Cited by 116
van Binnendijk, R. S., van der Heijden, R. W. J., van Amerongen, G., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.2.443 · Cited by 116
Preliminary Tests of a Highly Attenuated Measles Vaccine
Schwarz, A. J. F. (1962) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1962.02080020398042 · Cited by 115
Intertypic genomic rearrangements of poliovirus strains in vaccinees
CAMMACK, N., PHILLIPS, A., DUNN, G., PATEL, V, & MINOR, P. (1988) · Virology · doi:10.1016/s0042-6822(88)90113-4 · Cited by 111
Self-citationIntertypic genomic rearrangements of poliovirus strains in vaccinees
Cammack, N. C., Phillips, A., Dunn, G., Patel, V., & Minor, P. D. (1988) · Virology · doi:10.1016/0042-6822(88)90113-4 · Cited by 111
Self-citationDevelopment and evaluation of the Moraten measles virus vaccine.
Hilleman, M. R., Buynak, E. B., Weibel, R. E., et al. (1968) · PubMed · Cited by 109
WEIHL, C. (1971) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1971.02110020116026 · Cited by 109
Macadam, A. I., Pollard, S., Ferguson, G. L., Dunn, G., Skuce, R., Almond, J. W., & Minor, P. D. (1991) · Virology · doi:10.1016/0042-6822(91)90877-e · Cited by 105
Self-citationSabin, A. B. (1991) · European Journal of Epidemiology · doi:10.1007/bf00221337 · Cited by 98
Chapter 1 The Pathogenesis of Poliomyelitis: What We Don't Know
Nathanson, N. (2008) · Advances in Virus Research · doi:10.1016/s0065-3527(08)00001-8 · Cited by 95
Dunn, G., Begg, N. T., Cammack, N., & Minor, P. D. (1990) · Journal of Medical Virology · doi:10.1002/jmv.1890320205 · Cited by 94
Self-citationMeasles Vaccines: A Review of Adverse Events
DUCLOS, P. J., & Ward, B. J. (1998) · Drug Safety · doi:10.2165/00002018-199819060-00002 · Cited by 92
Miller, E. (1995) · Vaccine · doi:10.1016/0264-410x(94)00086-3 · Cited by 91
Cheek, J. E. (1995) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1995.02170200064010 · Cited by 90
Viscerotropic disease following yellow fever vaccination in Peru
Whittembury, Á., Ramírez, G., Hernández, H., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.082 · Cited by 90
Macadam, A. J., Ferguson, G., Stone, D. M., Meredith, J., Knowlson, S., Auda, G., Almond, J. W., & Minor, P. D. (2006) · Journal of Virology · doi:10.1128/jvi.00370-06 · Cited by 89
Self-citationMinor, P. D., Dunn, G., Evans, D. M. A., Magrath, D. I., John, A., Howlett, J., Phillips, A., Westrop, G., Wareham, K., Almond, J. W., et al. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-5-1117 · Cited by 82
Self-citationComparative biochemical studies of type 3 poliovirus
Minor, P. D. (1980) · Journal of Virology · doi:10.1128/jvi.34.1.73-84.1980 · Cited by 79
Self-citationThe Jeryl Lynn Vaccine Strain of Mumps Virus is a Mixture of Two Distinct Isolates
Afzal, M., Pickford, A. R., Forsey, T., Heath, A., & Minor, P. D. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-5-917 · Cited by 78
Self-citationThe polio-eradication programme and issues of the end game
Minor, P. D. (2011) · Journal of General Virology · doi:10.1099/vir.0.036988-0 · Cited by 75
Self-citationRNA sequence variants in live poliovirus vaccine and their relation to neurovirulence
Chumakov, K. M., Norwood, L. P., Parker, M. L., Dragunsky, E. M., Ran, Y. X., & Levenbook, I. S. (1992) · Journal of Virology · doi:10.1128/jvi.66.2.966-970.1992 · Cited by 72
Measles: immune suppression and immune responses
Moss, W. J., Ota, M. O. C., & Griffin, D. E. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.01.019 · Cited by 69
Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity
Sauder, C. J., Vandenburgh, K. M., Iskow, R. C., Malik, T., Carbone, K. M., & Rubin, S. A. (2006) · Virology · doi:10.1016/j.virol.2006.01.035 · Cited by 67
da Cunha, S. S., Rodrigues, L. C., Barreto, M. L., & Dourado, I. C. (2002) · Vaccine · doi:10.1016/s0264-410x(01)00438-8 · Cited by 67
A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating
Tatem, J. M., Weeks-Levy, C., Georgiu, A. F., Dimichele, S. J., Gorgacz, E. J., Racaniello, V. R., Cano, F. R., & Mento, S. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.3194-3197.1992 · Cited by 63
Afzal, M. A., Ozoemena, L. C., O'Hare, A. E., Kidger, K. A., Bentley, M. L., & Minor, P. D. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20585 · Cited by 59
Self-citationMethods for screening the naturally acquired and vaccine-induced immunity to the mumps virus
CHRISTENSON, B., & Böttiger, M. (1990) · Biologicals · doi:10.1016/1045-1056(90)90009-o · Cited by 56
Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials
Beck, M., Welsz-Malecek, R., Mesko-Prejac, M., Radman, V., Juzbasic, M., Rajninger-Miholic, M., Prislin-Musklic, M., Dobrovsak-Sourek, V., Smerdel, S., & Stainer, D. W. (1989) · Journal of Biological Standardization · doi:10.1016/0092-1157(89)90031-0 · Cited by 55
Studies in smallpox and vaccination†
Baxby, R. B. D. (2002) · Reviews in Medical Virology · doi:10.1002/rmv.361 · Cited by 52
Complications of mumps vaccines
Balraj, V., & Miller, E. (1995) · Reviews in Medical Virology · doi:10.1002/rmv.1980050406 · Cited by 49
Measles Vaccines Used in Japan
Hirayama, M. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.3.495 · Cited by 48
Detectionof reverse transcriptase activity in live attenuated virus vaccines
Böni, J., Stalder, J., Reigel, F., & Schüpbach, J. (1996) · Clinical and Diagnostic Virology · doi:10.1016/0928-0197(95)00159-x · Cited by 48
An increase in the number of mumps cases in the Czech Republic, 2005-2006
Boxall, N., Kubínyiová, M., Príkazský, V., et al. (2008) · Eurosurveillance · doi:10.2807/ese.13.16.18842-en · Cited by 48
Assay of humoral immunity to mumps virus
Pipkin, P. A., Afzal, M., Heath, A., & Minor, P. D. (1999) · Journal of Virological Methods · doi:10.1016/s0166-0934(99)00019-1 · Cited by 46
Self-citationDevelopment and Characteristics of Live AIK-C Measles Virus Vaccine: A Brief Report
Makino, S. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.3.504 · Cited by 46
Resurgence of mumps in Singapore caused by the Rubini mumps virus vaccine strain
Goh, K. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02853-6 · Cited by 43
Deshpande, J. M., Nadkarni, S. S., & Siddiqui, Z. A. (2003) · PubMed · Cited by 42
Atypical Measles in Adolescent Siblings 16 Years After Killed Measles Virus Vaccine
Fulginiti, V. A., & Helfer, R. E. (1980) · JAMA · doi:10.1001/jama.1980.03310080038022 · Cited by 29
Transmission of the L-Zagreb mumps vaccine virus, Croatia, 2005-2008
Kaić, B., Gjenero-Margan, I., Aleraj, B., Ljubin-Šternak, S., Vilibić‐Čavlek, T., Kilvain, S., Pavić, I., Unic-Stojanovic, D. R., & Ilic, A. (2008) · Eurosurveillance · doi:10.2807/ese.13.16.18843-en · Cited by 28
The work of the WHO Consultative Group on Poliomyelitis Vaccines.
Wc, C. (1988) · Europe PMC (PubMed Central) · Cited by 22
(1981) · Journal of Biological Standardization · doi:10.1016/s0092-1157(81)80021-2 · Cited by 20
Mumps Caused by an Inadequately Attenuated Measles, Mumps and Rubella Vaccine
Bakker, W. M., & Mathias, R. G. (2001) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2001/910649 · Cited by 16
Comparative monkey neurovirulence of sabin type III poliovirus vaccines
Boulger, L. R., Marsden, S. A., Magrath, D. I., et al. (1979) · Journal of Biological Standardization · doi:10.1016/s0092-1157(79)80042-6 · Cited by 14
Loss in Virulence of Yellow Fever Virus Serially Passed in HeLa Cells
Hearn, H. J., Soper, W. T., & MILLER, W. (1965) · Experimental Biology and Medicine · doi:10.3181/00379727-119-30167 · Cited by 14
Sharma, H. J., Aly Oun, S., Abou Bakr, S. S., Kapre, S. V., Jadhav, S. S., Dhere, R. M., & Bhardwaj, S. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03121.x · Cited by 13
Monkey neurovirulence of live, attenuated (Sabin) type I and type II poliovirus vaccines
Marsden, S. A., Boulger, L. R., Magrath, D. I., et al. (1980) · Journal of Biological Standardization · doi:10.1016/s0092-1157(80)80008-4 · Cited by 9
Considerations for setting the specifications of vaccines
Minor, P. D. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.23 · Cited by 9
Self-citation
Cited by
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Pardi, N., Hogan, M. J., Pelc, R. S., Muramatsu, H., Andersen, H., DeMaso, C. R., Dowd, K. A., Sutherland, L. L., Scearce, R. M., Parks, R., et al. (2017) · Nature · doi:10.1038/nature21428 · Cited by 884
Karbalaei, M., Rezaee, S. A., & Farsiani, H. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29583 · Cited by 710
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
Kyriakidis, N. C., López-Cortés, A., González, E. V., Grimaldos, A. B., & Prado, E. O. (2021) · npj Vaccines · doi:10.1038/s41541-021-00292-w · Cited by 698
A systematic review of SARS-CoV-2 vaccine candidates
Dong, Y., Dai, T., Wei, Y., Zhang, L., Zheng, M., & Zhou, F. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00352-y · Cited by 545
Coronavirus vaccine development: from SARS and MERS to COVID-19
Li, Y.-D., Chi, W.-Y., Su, J.-H., Ferrall, L., Hung, C.-F., & Wu, T.-C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00695-2 · Cited by 453
Metadata
- Authors
- Minor, P. D.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 479-480
- Pages
- 379-392
- ISSN
- 0042-6822 (ISSN-L)
- OpenAlex
- W2000920812
- Cited by
- 495
- References
- 88
- FWCI
- 11.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.